Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Morphle Labs
AddedMar 22, 2024
UpdatedJun 18, 2026
Morphle Labs

Morphle Labs

Seed

AI-enabled robotic whole slide scanner provider for pathology labs, hospitals, and research institutes.

HQ
Bangalore, Karnataka, IN
Founded
2017
Accelerator
Y Combinator logoY CombinatorW20
Overview
Compare
Fundraising
Employees
Website

Morphle Labs, founded with the mission to revolutionize pathology through advanced technology, focuses on providing AI-enabled robotic whole slide scanners. Their core vision is to enhance diagnostic accuracy and efficiency in pathology labs, cancer hospitals, and research institutes. Morphle Labs offers plug-and-play whole slide scanners that deliver superior image quality, rapid scanning, and state-of-the-art image analysis tools, all at competitive prices.

Notable figures associated with Morphle Labs include experts in AI and medical imaging, though specific names are not provided. The company has achieved significant milestones in improving diagnostic workflows and reducing costs for medical institutions. Morphle Labs' impact is evident in its contribution to more accurate and timely diagnoses, ultimately aiding in better patient outcomes and advancing research capabilities in the medical field.

Morphle Labs - Similar Companies

Instapath Inc. logo

Instapath Inc.

instapathbio.com

HistoWiz logo

HistoWiz

histowiz.com

RoboPath logo

RoboPath

robopath.io

Pictor Labs logo

Pictor Labs

VistaPath Biosystems logo

VistaPath Biosystems

vistapath.ai

Pathware logo

Pathware

pathware.com

Dashlabs.ai logo

Dashlabs.ai

dashlabs.ai

Scanbase logo

Scanbase

scanbase.com

Clarapath logo

Clarapath

clarapath.com

Alexapath logo

Alexapath

alexapath.com

Airilabs logo

Airilabs

Pramana logo

Pramana

pramana.ai

Biodock logo

Biodock

biodock.ai

Histolix logo

Histolix

histolix.com

Proscia logo

Proscia

proscia.com

Morphle Labs - Quick Facts

Who are Morphle Labs' competitors?

Companies similar to Morphle Labs include Instapath Inc., HistoWiz, RoboPath and Pictor Labs.

When was Morphle Labs founded?

Morphle Labs was founded in 2017.

Where is Morphle Labs' headquarters located?

Morphle Labs' headquarters is located in Bangalore, Karnataka, IN.

When was Morphle Labs' last funding round?

Morphle Labs' most recent funding round was for $1.2M (USD) in May 2022.

How much has Morphle Labs raised to-date?

As of May 1, 2022, Morphle Labs has raised a total of $2.4M (USD).

How many employees does Morphle Labs have?

Morphle Labs has 75 employees as of Feb 24, 2024.

Morphle Labs - Classification

Industry
  • Hardware
Technology
  • AI
  • Robotics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Medical Scanners
Tags
  • AI Operations
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software